I would be very surprised if it was Peak.
Why?
The recent Cap Raise had attaching options that expire in May 24. That's a hint of an outside timeline.
The investment thesis was:
- good results from Phase 1B trials
- followed by partnership and/or licencing
The Phase 1B trial was blind so not even the coy would know the results until supplied.
As with many a biotech, the results are complex but the outcome is usually binary.
Good luck to us.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $2.142M | |||
| Open | High | Low | Value | Volume |
| 0.2¢ | 0.2¢ | 0.2¢ | $5.1K | 2.55M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 27 | 21738357 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 4679253 | 11 |
View Market Depth
| Last trade - 16.10pm 17/06/2025 (20 minute delay) ? |
| 1AD (ASX) Chart |